Washington Grove, MD, United States of America

JoAnne A Suzich

This inventor holds 2 USPTO granted patents. Top assignee: Medimmune Limited. Active years: 2005-2008.


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2005-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: JoAnne A Suzich: Innovator in Papillomavirus Research

Introduction

JoAnne A Suzich is a prominent inventor based in Washington Grove, MD (US). She has made significant contributions to the field of virology, particularly in the development of methods related to papillomavirus virus-like particles (VLPs). With a total of 2 patents, her work has implications for both therapeutic and diagnostic applications.

Latest Patents

Suzich's latest patents include an innovative in vitro method for the disassembly and reassembly of papillomavirus VLPs. This method results in homogeneous VLP and capsomere compositions that serve as vehicles for improved purification and delivery of active agents. The resultant VLPs exhibit enhanced homogeneity and present conformational, neutralizing PV epitopes, making them useful as prophylactic and diagnostic agents. Furthermore, these VLPs can encapsulate desired moieties, such as therapeutic or diagnostic agents, and can be utilized as in vivo delivery vehicles or pseudovirions for evaluating vaccine efficacy.

Career Highlights

JoAnne A Suzich has established herself as a key figure in her field through her innovative research and development efforts. She is currently associated with MedImmune Limited, where she continues to advance her work in virology and vaccine development.

Collaborations

One of her notable collaborators is Michael P McCarthy, with whom she has worked closely on various projects related to her patents and research initiatives.

Conclusion

JoAnne A Suzich's contributions to the field of papillomavirus research highlight her role as an influential inventor. Her innovative methods and collaborative efforts continue to pave the way for advancements in vaccine efficacy and therapeutic delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…